Merck & Co., Inc. vs Reddit Inc — how do they compare? Merck & Co., Inc. trades at $146.2 (market cap $351.28B), while Reddit Inc trades at $159.65 (market cap $30.10B). The key difference: Merck & Co., Inc. is far larger — about 11.7× Reddit Inc's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Reddit Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Reddit Inc for 26 Days on average.
| MRK | RDDT | |
|---|---|---|
Market Cap | $351.28B | $30.10B |
Volume | 7,969,665 | 4,560,440 |
Sector | Health | Media |
52-Week High | $156.43 | $258.93 |
52-Week Low | $82.49 | $121.84 |
Typical Hold Time | 98 Days | 26 Days |
Enterprise Value | $398.04B | $27.34B |
Dividend Yield | 2.39% | — |
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $145.6, up 1.97% today, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, and the company is expanding its oncology pipeline through the acquisition of Terns Pharmaceuticals. Revenue growth is steady, with 2025 revenue at $65.01B and net income of $18.25B, though 2026 projections show a significant drop in net income to $3.2B. The stock is supported by a high analyst buy consensus of 68.42% and a price target of $158.78.
The outlook for MRK is mixed; strong earnings beats and strategic acquisitions provide upside potential, but high valuation ratios and a projected earnings decline in 2026 pose risks. Investors should weigh the company's robust profitability and analyst support against execution risks and market volatility.
Reddit (RDDT) trades at $159.84, up 4.63% today, showing strong momentum after three consecutive quarterly earnings beats. The stock maintains a bullish technical outlook with support at $154 and resistance at $160. Fundamentally, the company demonstrates exceptional profitability with 91.44% gross margins and 31.35% net income margins, while revenue growth accelerated to $2.8 billion in 2026. Recent developments include a strategic partnership with Zefr for AI-powered advertising solutions and expanding international revenues by 84%.
The investment outlook remains positive with 65.5% analyst buy ratings and a $202.52 consensus price target representing 27% upside potential. Key opportunities include continued AI data licensing growth and international expansion, while risks involve competitive pressure from Meta and regulatory concerns. The stock's premium valuation at 36.4x P/E requires sustained execution to justify current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →